Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience

by Tatar,Bengu, Köse,Şükran, Ergun,Nadide Colak, Turken,Melda, Onlen,Yusuf, Yılmaz,Yusuf, Akhan,Sıla
Published 2019

Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program

by Köklü,Seyfettin, Köksal,Iftihar, Salih Akarca,Ulus, Balkan,Ayhan, Güner,Rahmet, Demirezen,Aylin, Sahin,Memduh, Akhan,Sila, Ozaras,Resat, Idilman,Ramazan
Published 2017